What is the best management approach for a patient with asthma who experiences more than 6 respiratory illnesses per year and only uses their inhaler when symptomatic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Poorly Controlled Asthma with Frequent Respiratory Illnesses

This 30-year-old patient requires immediate initiation of daily inhaled corticosteroid (ICS) therapy, as using a rescue inhaler only when sick represents inadequate treatment and places her at ongoing risk for exacerbations and progressive airway remodeling. 1

Classification and Treatment Indication

This patient has persistent asthma, not intermittent asthma, based on the frequency of respiratory illnesses requiring inhaler use (>6 times per year). 2

Daily long-term controller therapy is indicated when any of the following criteria are met: 2

  • Symptomatic treatment required >2 days per week for >4 weeks
  • ≥2 exacerbations requiring systemic corticosteroids within 6 months
  • Frequent interruptions of sleep or daily activities

The pattern of needing treatment during respiratory illnesses more than 6 times yearly clearly meets these thresholds for persistent asthma requiring daily controller medication. 1

Recommended Treatment Approach

Initial Controller Therapy

Start low-dose inhaled corticosteroid (ICS) as the foundation of treatment. 1 This is the preferred first-line controller medication for persistent asthma in adults. 2

For patients aged 12 years and older with mild persistent asthma, two evidence-based options exist: 2

  • Low-dose ICS daily plus as-needed short-acting beta-agonist (SABA)
  • As-needed combination ICS-formoterol (for patients who may have adherence challenges with daily therapy)

Rescue Medication Strategy

Continue short-acting beta-agonist (albuterol/salbutamol) for acute symptom relief, but emphasize this should not be the sole therapy. 1

Critical teaching point: If SABA use exceeds 2-3 times daily or symptoms remain inadequately controlled, treatment must be stepped up. 1

Essential Management Components

Peak Flow Monitoring and Self-Management Plan

Provide a peak expiratory flow (PEF) meter and teach proper technique. 2 The patient should: 2

  • Monitor PEF regularly to track asthma control
  • Know specific PEF values at which to increase treatment
  • Know when to call their doctor
  • Know when to seek emergency care

Develop a written asthma action plan that specifies: 2, 1

  • Daily controller medication regimen
  • When and how to use rescue medication
  • Signs of worsening asthma
  • Specific actions to take during exacerbations

Inhaler Technique Verification

Check and document proper inhaler technique at every visit, as poor technique is a common cause of treatment failure. 2 If the patient cannot use a metered-dose inhaler (MDI) properly, add a large volume spacer device or consider alternative delivery devices. 1

Addressing the Root Problem

Why Current Approach Is Inadequate

Using rescue medication only during illness represents reactive rather than preventive management, which: 1

  • Fails to control underlying airway inflammation
  • Increases risk of severe exacerbations
  • May lead to progressive airway remodeling
  • Results in preventable morbidity

The dissociation between symptoms and inflammation means that waiting until symptoms appear to treat asthma misses the opportunity to prevent exacerbations. 3

Follow-Up Schedule

Schedule follow-up within 1-4 weeks after initiating controller therapy to: 2

  • Assess response to treatment
  • Verify adherence and proper technique
  • Adjust therapy if needed

Ongoing monitoring intervals should be 1-6 months depending on control level, with closer follow-up for newly initiated therapy. 2

Stepping Up Therapy If Needed

If asthma remains uncontrolled on low-dose ICS after 3 months of adequate adherence and proper technique: 2, 1

  • Add long-acting beta-agonist (LABA) to ICS (combination inhaler such as fluticasone-salmeterol)
  • Consider increasing ICS dose
  • Evaluate for alternative diagnoses or comorbidities

Common Pitfalls to Avoid

Do not accept SABA-only treatment as adequate for this patient—this is the most critical error to correct. 1

Do not assume respiratory illnesses are separate from asthma—these likely represent asthma exacerbations triggered by viral infections, which daily ICS can help prevent. 2

Do not delay referral to a specialist if the patient experiences life-threatening exacerbations, requires frequent oral corticosteroids, or remains uncontrolled despite appropriate step-up therapy. 4, 5

Ensure the patient understands this is chronic disease management, not just treatment of acute episodes, and that daily controller medication is necessary even when feeling well. 6

References

Guideline

Asthma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute asthma, prognosis, and treatment.

The Journal of allergy and clinical immunology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.